CAPTRUST Financial Advisors’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
+3,005
New +$171K ﹤0.01% 2865
2026
Q1
Sell
-1,876
Closed -$244K 3129
2025
Q4
$244K Buy
+1,876
New +$257K ﹤0.01% 2394
2022
Q3
Sell
-76
Closed -$3K 4056
2022
Q2
$3K Sell
76
-60
-44% -$4.07K ﹤0.01% 4355
2022
Q1
$14K Buy
136
+82
+152% +$9.12K ﹤0.01% 3626
2021
Q4
$8K Buy
54
+26
+93% +$5.81K ﹤0.01% 3860
2021
Q3
$7K Buy
28
+23
+460% +$7.9K ﹤0.01% 3823
2021
Q2
$2K Buy
5
+2
+67% +$859 ﹤0.01% 4215
2021
Q1
$1K Buy
+3
New +$1.56K ﹤0.01% 4251

Other funds holding WGS

CAPTRUST Financial Advisors's WGS Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in GeneDx Holdings (WGS) in Q2 2026: 3,005 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #2865 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in WGS as recently as Q4 2025.

CAPTRUST Financial Advisors first reported a position in WGS in Q1 2021 and has held it in 8 quarters since. The position peaked at $244K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • CAPTRUST Financial Advisors held 3,005 shares of GeneDx Holdings worth $206K as of Q2 2026.
  • GeneDx Holdings was a new CAPTRUST Financial Advisors position in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2865 holding.
  • CAPTRUST Financial Advisors first reported a position in GeneDx Holdings in Q1 2021 and has held it in 8 quarters since.
  • CAPTRUST Financial Advisors's GeneDx Holdings position peaked at $244K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.